The palliative value of tumor necrosis factor α-based isolated limb perfusion in patients with metastatic sarcoma and melanoma

Keyphrases

• Amputation 50%
• Complete Response Rate 16%
• Extremity Soft Tissue Sarcoma 16%
• Extremity Tumors 16%
• In-transit Metastasis 16%
• Isolated Limb Perfusion 100%
• Limb Salvage 33%
• Limited Treatment 16%
• Locally Advanced 16%
• Lower Limb 16%
• Median Survival 33%
• Melanoma 83%
• Melphalan 33%
• Metastasizing 50%
• Metastatic Melanoma 100%
• Metastatic Sarcoma 100%
• Patient Survival 16%
• Soft Tissue Sarcoma 66%
• Stage IV Melanoma 16%
• Treatment Options 16%
• Treatment Toxicity 16%
• Tumor 33%
• Tumor Burden 16%
• Tumor Control 16%
• Tumor Necrosis Factor-α 100%
• Upper Limb 16%

Medicine and Dentistry

• Amputation 42%
• Connective Tissue Cancer 100%
• Disease 14%
• In-Transit Metastasis 14%
• Limb 28%
• Limb Perfusion 100%
• Limb Salvage 42%
• Limb Tumor 14%
• Lower Limb 14%
• Melanoma 100%
• Melphalan 28%
• Neoplasm 57%
• Soft Tissue Sarcoma 71%
• Tumor Necrosis Factor 100%
• Upper Limb 14%